André Michel

GPR55 as a New Cannabinoid Receptor: Still a Long Way to Prove It

François Petitet, Mary Donlan, André Michel · Chemical Biology & Drug Design · 2006 · 65 citations

In Silico Classification of hERG Channel Blockers: a Knowledge‐Based Strategy

Elodie Dubus, Ismaïl Ijjaali, François Petitet et al. · ChemMedChem · 2006 · 47 citations · Full text

Translational Medicine, Heart Failure, Diverse Compounds +12

Pharmacophoric Search and 3D-QSAR Comparative Molecular Field Analysis Studies on Agonists of Melatonin Sheep Receptors

Christophe Marot, Philippe Chavatte, Luc Morin‐Allory et al. · Journal of Medicinal Chemistry · 1998 · 45 citations · Full text

Drug Target, Active Ligands, Pharmacotherapy +16

Recursive Partitioning for the Prediction of Cytochromes P450 2D6 and 1A2 Inhibition:  Importance of the Quality of the Dataset

J. S. Burton, Ismaïl Ijjaali, Olivier Barberan et al. · Journal of Medicinal Chemistry · 2006 · 44 citations

A Three Binding Site Hypothesis for the Interaction of Ligands with Monoamine G Protein-coupled Receptors: Implications for Combinatorial Ligand Design

Edgar Jacoby, Jean‐Luc Fauchère, Eric Raimbaud et al. · Quantitative Structure-Activity Relationships · 1999 · 30 citations

Drug Target, Molecular Biology, Peptide Science +21